Basel Medical Group Ltd (BMGL)
| Market Cap | 83.05M |
| Revenue (ttm) | 12.87M |
| Net Income (ttm) | 3.31M |
| Shares Out | 18.46M |
| EPS (ttm) | 0.18 |
| PE Ratio | 25.12 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About BMGL
Basel Medical aims to be a one-stop integrated healthcare provider for all musculoskeletal-related medical care, including post-surgery rehabilitation services such as physiotherapy as well as other ancillary services such as pain management. We operate our two clinics at Gleneagles Medical Centre in Singapore and currently have five medical practitioners practicing with Basel Medical, comprising four orthopedic specialists and one neurosurgery specialist. The services provided by our clinics include, but are not limited to, consultation, medic... [Read more]
News
Singapore health care practice Basel Medical Group files for a $6 million US IPO
Basel Medical Group, which operates two medical clinics in Singapore, filed on Friday with the SEC to raise up to $6 million in an initial public offering.
Basel Medical Group IPO Registration Document (F-1)
Basel Medical Group has filed to go public with an IPO on the NASDAQ.